277 related articles for article (PubMed ID: 16208664)
1. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
Blalock SJ; Norton LL; Patel RA; Dooley MA
Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
4. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
[TBL] [Abstract][Full Text] [Related]
5. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
6. Barriers in the management of glucocorticoid-induced osteoporosis.
Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis prevention: pediatricians' knowledge, attitudes, and counseling practices.
Fleming R; Patrick K
Prev Med; 2002 Apr; 34(4):411-21. PubMed ID: 11914047
[TBL] [Abstract][Full Text] [Related]
9. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
[TBL] [Abstract][Full Text] [Related]
10. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of glucocorticoid-induced osteoporosis.
Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
[TBL] [Abstract][Full Text] [Related]
12. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
Gera C; Vij AS
Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
16. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
17. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
[TBL] [Abstract][Full Text] [Related]
18. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; Peñuela-Epalza M
J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
[TBL] [Abstract][Full Text] [Related]
19. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
[TBL] [Abstract][Full Text] [Related]
20. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]